<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/63498FF9-9FAB-416A-919E-6AADB8C1A11B"><gtr:id>63498FF9-9FAB-416A-919E-6AADB8C1A11B</gtr:id><gtr:name>Technical University of Lisbon</gtr:name><gtr:address><gtr:line1>Alameda de St Antonio dos</gtr:line1><gtr:line2>de Capuchos 1</gtr:line2><gtr:line4>Lisboa</gtr:line4><gtr:line5>1169 047</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Portugal</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/98A0166A-44D7-44A0-8876-7824EA20BF4B"><gtr:id>98A0166A-44D7-44A0-8876-7824EA20BF4B</gtr:id><gtr:name>School of Biomedical Sciences</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/63498FF9-9FAB-416A-919E-6AADB8C1A11B"><gtr:id>63498FF9-9FAB-416A-919E-6AADB8C1A11B</gtr:id><gtr:name>Technical University of Lisbon</gtr:name><gtr:address><gtr:line1>Alameda de St Antonio dos</gtr:line1><gtr:line2>de Capuchos 1</gtr:line2><gtr:line4>Lisboa</gtr:line4><gtr:line5>1169 047</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Portugal</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/98A0166A-44D7-44A0-8876-7824EA20BF4B"><gtr:id>98A0166A-44D7-44A0-8876-7824EA20BF4B</gtr:id><gtr:name>School of Biomedical Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6E21A7D6-BE0F-45B5-9AAD-25FE1CE982B1"><gtr:id>6E21A7D6-BE0F-45B5-9AAD-25FE1CE982B1</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:surname>ffrench-Constant</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0601744"><gtr:id>FF675475-1565-46C5-B63D-94154A818EFD</gtr:id><gtr:title>A functional proteomic screen of myelination</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601744</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Myelination represents one of the most spectacular cell-cell interactions in biology. Despite
this, we know very few of the signalling molecules involved in axo-glial adhesion and/or in
ensuring that the number of wraps is precisely related to axon diameter. Identification of
these molecules will provide therapeutic targets for remyelination strategies in Multiple
Sclerosis (MS), the failure of which results in the axon loss and progressive disability that
characterises the disease. As well as representing a major disease burden to sufferers and
their families, the chronic progressive nature of MS causes a significant cost to society ?
currently estimated at 5-13 billion euros/annum in the EU. Currently there are no therapies
in clinical use or even in trials to promote remyelination, in large part due to the lack of
targets. We propose a novel approach to the problem by using a combination of
monoclonal antibody and recombinant phage display technology with FALI (fluorophoreassisted
light inactivation), a technique to create acute protein knockdown of antibodybinding
targets by singlet oxygen-mediated protein damage when the fluorophore is
exposed to light. We will generate libraries of monoclonal antibodies or single-chain
variable fragments (scFvs) by immunizing mice with oligodendrocytes, the myelin-forming
cells of the CNS. We will screen these for surface binding to oligodendrocytes, then couple
those that bind to a fluorochrome (FITC) and determine which inhibit myelination following
exposure to 490nm light in a neurone/oligodendrocyte myelinating co-culture assay.
Proteomics will then be used to identify the target antigens for those that inhibit
myelination, so defining signalling molecules for validation by conventional transgenic
techniques. The use of monoclonal antibody technology and FALI provides an unbiased
approach for the identification of key signalling molecules quite distinct from conventional
candidate-driven approaches.t therefore provides a method both to understand this
essential part of CNS development and also to identify entirely new targets for
remyelination therapies that will not be detected by conventionally-funded incremental
research programmes.</gtr:technicalSummary><gtr:fund><gtr:end>2009-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-12-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>447267</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>work on polarity</gtr:description><gtr:id>CD812C9F-D571-45EB-83B6-0254D5940AC0</gtr:id><gtr:impact>No outputs in 2012</gtr:impact><gtr:partnerContribution>Specialist knowledge and analysis of tissue samples</gtr:partnerContribution><gtr:piContribution>Post doc in my lab working on Scribble function in myelination</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Braod image analysis</gtr:description><gtr:id>78DF9A5B-D2F7-4EEB-B5AD-4E404DD89EBE</gtr:id><gtr:impact>none to date</gtr:impact><gtr:partnerContribution>Development of machine learning image analysi protocols</gtr:partnerContribution><gtr:piContribution>Definition of the problem of quantifying myelin sheaths</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Disc1 SC</gtr:description><gtr:id>337AC2D2-0526-4976-91A4-8ECBB4CBDE86</gtr:id><gtr:impact>none to date</gtr:impact><gtr:partnerContribution>Human cells and initial results</gtr:partnerContribution><gtr:piContribution>New research tools - fibres</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Lisbon</gtr:collaboratingOrganisation><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:description>work on myelination and bilirubin</gtr:description><gtr:id>17EFE98B-71E4-427C-93FC-40B65DC47325</gtr:id><gtr:impact>Co-publications since 2011 23086523</gtr:impact><gtr:partnerContribution>Student working on project</gtr:partnerContribution><gtr:piContribution>Trained student in her lab in cell culture</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>joint projects on CNS remyelination</gtr:description><gtr:id>4136A421-6B16-4F77-AED1-8DEFB8A0A298</gtr:id><gtr:impact>Co-publications since 2011 23026979 and 21904791 and 21469916 and 21131950</gtr:impact><gtr:partnerContribution>Specialist knowledge and experimental work on parabiosis model</gtr:partnerContribution><gtr:piContribution>Post docs in my lab working on macrophage biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biomedical Sciences</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Neuroregeneration (CNR)</gtr:department><gtr:description>Zebrafish collaboration</gtr:description><gtr:id>5FD8805E-84E3-475E-8BDA-B7496F15BF19</gtr:id><gtr:impact>Publication in development</gtr:impact><gtr:partnerContribution>Publication in Development</gtr:partnerContribution><gtr:piContribution>expertise in oligodendrocyte morphology during myelination</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biomedical Sciences</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Neuroregeneration (CNR)</gtr:department><gtr:description>Axoglial interactions</gtr:description><gtr:id>7E0069F2-A97D-4A4E-9AD3-C213FB82E1DC</gtr:id><gtr:impact>Wellcome Trust Programme Grant Publication 19451276</gtr:impact><gtr:partnerContribution>Intellectual input and regular meetings</gtr:partnerContribution><gtr:piContribution>Analysis of cell adhesion molecules that regulate axoglial contact</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Experimental Medicine</gtr:department><gtr:description>Septin Werner</gtr:description><gtr:id>BBE39406-6322-4B35-A91A-25C229F7C8F6</gtr:id><gtr:impact>none to date</gtr:impact><gtr:partnerContribution>expert advice and septin antibodies</gtr:partnerContribution><gtr:piContribution>Discovery of myelin abnormalities that might be explained by septin mislocalization</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Edinburgh science festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>18C8BF39-F42E-474F-A62B-1B6E30F9CC2A</gtr:id><gtr:impact>Questions afterwards

none</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RSE lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9C973270-EC53-40CA-806D-7316949B0503</gtr:id><gtr:impact>Discussion about MS therapies

None</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talks to MS Society meetings</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8AC89F4D-8C66-4448-A6F7-364A3FBE922C</gtr:id><gtr:impact>Platform presentations at MS Meetings for patients

Dissemination of information, and funding donations to Society</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Charles frrench-Constant lecture at MS Space North annual meeting 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4BF905E1-FE9A-4E48-A0D5-337F748DB043</gtr:id><gtr:impact>MS Space North annual meeting, 16 August 2013, Exhibition Centre, Aberdeen, Scotland. Prof Charles ffrench-Constant was invited to give a keynote lecture. 150 patients with MS and their families attended. Lecture was recorded and is available online (214 views so far): http://www.mssociety.org.uk/ms-events/2013/06/ms-space-north-2013-aberdeen.

Part of a general objective of disseminating information concerning regenerative medicine, generating interest in this field.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.mssociety.org.uk/ms-events/2013/06/ms-space-north-2013-aberdeen</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Investigator award</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>5182815B-71BE-48D0-A473-98888868100E</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Edinburgh - MS Society Clinical Science Centre</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Multiple Sclerosis Society</gtr:fundingOrg><gtr:id>BDED290A-A354-4611-BE7A-CF564838ABCA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1610619</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>089000/Z/09/Z Wellcome Trust Programme Grant (Axoglial interactions during myelination in the CNS) PIs Brophy and French-Constant</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>089000/Z/09/Z</gtr:fundingRef><gtr:id>F0F0407F-FE9B-4E82-AF32-B43712F5DE79</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation (EMBO)</gtr:fundingOrg><gtr:id>1B3EDBD6-12B2-41B5-9216-5239B4731C41</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100706</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Are endothelin Receptors suitable targets for remyelination therapies?</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Multiple Sclerosis Society</gtr:fundingOrg><gtr:id>6B4A9807-6E94-4E0B-A66B-8607AC2255CE</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>BQ - Identification of Activin A as a novel target for remyelination therapy</gtr:description><gtr:id>0E5EEF38-3B77-4EAE-840F-22DB1F9380D6</gtr:id><gtr:impact>Priority</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>WO2007083133</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Patent - TECH ID TEC3348 - Charles ffrench-Constant</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Bristol review</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B621CBAE-2394-400C-AEA8-508120674A97</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BIRAX</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>3A0A5FB9-8B6E-4090-BE07-D23A5C38F022</gtr:id><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A robust myelination assay using purified oligodendrocyte precursors and dorsal root ganglion neurones. Enables drugs etc to be rapidly screened</gtr:description><gtr:id>E42B19B1-130E-4F12-A536-A77575098D15</gtr:id><gtr:impact>Nature neuroscience paper from collaboration with Robin Franklin (Cambridge) using the assay to examine RXR signalling.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>myelinating co-cultures</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Nanofibres to assess level of oligodendrocyte myelination</gtr:description><gtr:id>4C801055-51BF-440E-9BC8-3A27D81A7DFA</gtr:id><gtr:impact>Novel assay to look at myelination - used by other research groups</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CffC Fibre cultures</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>co-culture protocol that enables myelination signals to be assayed</gtr:description><gtr:id>085F6B68-8FAE-4EB2-AB4D-194C35360EAB</gtr:id><gtr:impact>By training post docs and students from labs in Europe in its use (2 in 2012).
Publications by other groups and refinement of myelination assays by replacing in vivo assays with an in vitro model</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CFFC - co-culture protocol that enables myelination signals to be assayed</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Use of fluorescent light to inactivate molecules on the surface of cells based on the release of free radicals by fluorochrome coupled antibodies attached to these cells</gtr:description><gtr:id>6E9DEF00-8307-4BCD-89E6-1B40F634F888</gtr:id><gtr:impact>Rapid assay for cell adhesion between axons and glai</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>FALI</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D58D6692-A2DB-4841-BCED-D0D2BA7F9F4B"><gtr:id>D58D6692-A2DB-4841-BCED-D0D2BA7F9F4B</gtr:id><gtr:title>Extracellular matrix and the neural stem cell niche.</gtr:title><gtr:parentPublicationTitle>Developmental neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a16f5e538385a01670bdce9acbab2cb1"><gtr:id>a16f5e538385a01670bdce9acbab2cb1</gtr:id><gtr:otherNames>Kazanis I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-8451</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5B6D0A7-D2CC-4BE4-9345-41AC70F335E1"><gtr:id>B5B6D0A7-D2CC-4BE4-9345-41AC70F335E1</gtr:id><gtr:title>In vitro modeling of central nervous system myelination and remyelination.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f532343f4e7d0f21ed6778c0e32ce5b"><gtr:id>3f532343f4e7d0f21ed6778c0e32ce5b</gtr:id><gtr:otherNames>Jarjour AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A0EB1B04-26F4-45A3-A629-A848A8EA164F"><gtr:id>A0EB1B04-26F4-45A3-A629-A848A8EA164F</gtr:id><gtr:title>CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3fbac1208fdcce9e28478ed8bbd1bdcd"><gtr:id>3fbac1208fdcce9e28478ed8bbd1bdcd</gtr:id><gtr:otherNames>Bechler ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4CD66EBE-FF74-4802-909C-0F5EC0A8BE72"><gtr:id>4CD66EBE-FF74-4802-909C-0F5EC0A8BE72</gtr:id><gtr:title>An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/513fbeda5cc6cfa5948105ba35d0996d"><gtr:id>513fbeda5cc6cfa5948105ba35d0996d</gtr:id><gtr:otherNames>Laursen LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C66E7E2D-FCAD-48ED-AD9D-7AD22D968152"><gtr:id>C66E7E2D-FCAD-48ED-AD9D-7AD22D968152</gtr:id><gtr:title>Integrin-mediated axoglial interactions initiate myelination in the central nervous system.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bda65f2a89d4df64727a19874368f1dc"><gtr:id>bda65f2a89d4df64727a19874368f1dc</gtr:id><gtr:otherNames>C?mara J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F346E9FE-55EF-4997-BF94-E7392D66A1A9"><gtr:id>F346E9FE-55EF-4997-BF94-E7392D66A1A9</gtr:id><gtr:title>Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cdc1c73342550c62c360ac1d42acd6d6"><gtr:id>cdc1c73342550c62c360ac1d42acd6d6</gtr:id><gtr:otherNames>Barateiro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7C0F019-05F1-400D-B8B6-D815298A1643"><gtr:id>D7C0F019-05F1-400D-B8B6-D815298A1643</gtr:id><gtr:title>Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9bd4b0634551aa6f41034b712d72fb90"><gtr:id>9bd4b0634551aa6f41034b712d72fb90</gtr:id><gtr:otherNames>Almeida RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5764D28A-938C-4FBF-928D-CCB64702FF5D"><gtr:id>5764D28A-938C-4FBF-928D-CCB64702FF5D</gtr:id><gtr:title>Hypomyelinating leukodystrophies: translational research progress and prospects.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbcf863d1bb205ae712260ac92374b39"><gtr:id>fbcf863d1bb205ae712260ac92374b39</gtr:id><gtr:otherNames>Pouwels PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C6AB237-70AE-424D-80F9-3B7A225E8082"><gtr:id>3C6AB237-70AE-424D-80F9-3B7A225E8082</gtr:id><gtr:title>Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4f8b01b67a62bc7c9582e263696a52c2"><gtr:id>4f8b01b67a62bc7c9582e263696a52c2</gtr:id><gtr:otherNames>Czopka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A074DE22-95D3-48D8-A9F1-5313498B268A"><gtr:id>A074DE22-95D3-48D8-A9F1-5313498B268A</gtr:id><gtr:title>Adhesion molecules in the regulation of CNS myelination.</gtr:title><gtr:parentPublicationTitle>Neuron glia biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/513fbeda5cc6cfa5948105ba35d0996d"><gtr:id>513fbeda5cc6cfa5948105ba35d0996d</gtr:id><gtr:otherNames>Laursen LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1740-925X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6A40AFDA-4277-4602-BA9D-A5E39D590E67"><gtr:id>6A40AFDA-4277-4602-BA9D-A5E39D590E67</gtr:id><gtr:title>Neuroscience. A new wrap for neuronal activity?</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3fbac1208fdcce9e28478ed8bbd1bdcd"><gtr:id>3fbac1208fdcce9e28478ed8bbd1bdcd</gtr:id><gtr:otherNames>Bechler ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601744</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>